Pharmacovigilance practices and adverse drug reaction reporting among hospital pharmacists in the Middle East

Read full text Summarise with VIRAT
Authors: Layla Mahmoud Al-Farsi, Khalid Bin Rashid, Maryam Al-Suwaidi
Cited by: 0
References: 14

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Adverse drug reactions remain one of the leading preventable causes of hospital morbidity across the Middle East, yet reporting rates in the region are among the lowest globally. This research assessed pharmacovigilance practices, ADR reporting behaviour, knowledge levels, and perceived barriers among hospital pharmacists across six Gulf Cooperation Council (GCC) countries: Oman, the United Arab Emirates, Saudi Arabia, Qatar, Kuwait, and Bahrain. A cross-sectional survey using a validated 48-item questionnaire was distributed electronically to hospital pharmacists between January and June 2023. A total of 487 pharmacists completed the survey, yielding a response rate of 58.6%. The mean ADR reporting knowledge score was 56.3 out of 100, with scores ranging from 51.8 in Kuwait to 62.4 in Saudi Arabia. Only 34.7% of respondents had ever submitted an ADR report to their national pharmacovigilance centre (NPC). Among those who had not reported, the most frequently cited barriers were lack of time (68.3%), uncertainty about whether the reaction was truly drug-related (54.7%), and complexity of reporting forms (47.2%). Pharmacists with formal pharmacovigilance training scored significantly higher on knowledge items (mean 67.1 vs 48.9, p

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Pharmacy and Medical Practices Complementary and Alternative Medicine Studies

Publication details

Journal / source
Journal of Pharmacist and Hospital Pharmacy
Volume
3
Issue
1
Pages
45–49
Publication date
1 January 2026
Language
EN